Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $747M | $820M | $868M | $1.13B | $1.42B | $1.76B | $1.94B | $1.95B | $1.84B | $1.89B |
| Revenue growth | — | 9.8% | 5.8% | 30.7% | 25.1% | 24.2% | 10.4% | 0.5% | -5.8% | 2.7% |
| Gross profit | — | $291M | $312M | $392M | $513M | $595M | $613M | $706M | $686M | $679M |
| Gross margin | — | 35.5% | 36.0% | 34.6% | 36.2% | 33.8% | 31.5% | 36.1% | 37.3% | 36.0% |
| Operating income | $85.4M | $62.7M | $87.8M | $46.1M | $59.4M | $150M | $52.3M | $214M | $195M | $53.0M |
| Operating margin | 11.4% | 7.7% | 10.1% | 4.1% | 4.2% | 8.5% | 2.7% | 11.0% | 10.6% | 2.8% |
| Net income | $61.4M | $20.3M | $59.5M | $31.6M | $39.7M | $121M | -$15.9M | $113M | $117M | -$2.49M |
| Net margin | 8.2% | 2.5% | 6.9% | 2.8% | 2.8% | 6.9% | -0.8% | 5.8% | 6.3% | -0.1% |
| EPS (diluted) | $4.63 | $1.52 | $4.45 | $2.08 | $2.22 | $6.77 | -$0.89 | $6.26 | $6.51 | -$0.14 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $73.8M | $64.8M | $78.8M | $82.4M | $178M | $48.9M | $41.8M | $279M | $205M | $136M |
| Capital expenditures | $9.95M | $10.9M | $12.9M | $15.5M | $17.9M | $21.5M | $28.5M | $38.8M | $41.8M | $55.9M |
| Free cash flow | $63.8M | $53.9M | $65.9M | $66.8M | $160M | $27.5M | $13.3M | $240M | $163M | $80.6M |
| Share buybacks | $5.86M | $0.00 | $0.00 | — | — | — | $0.00 | $0.00 | $49.2M | $41.5M |
| Dividends paid | $17.6M | $18.6M | $19.3M | $21.8M | $27.6M | $28.6M | $30.1M | $31.6M | $33.2M | $34.4M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $88.8M | $89.9M | $104M | $124M | $182M | $165M | $181M | $195M | $189M | $180M |
| Total assets | $692M | $722M | $710M | $2.85B | $2.89B | $2.96B | $2.82B | $2.71B | $2.61B | $2.80B |
| Total liabilities | $279M | $313M | $273M | $1.61B | $1.57B | $1.57B | $1.54B | $1.33B | $1.26B | $1.42B |
| Long-term debt | $65.8M | $61.1M | $35.9M | $882M | $849M | $836M | $934M | $731M | $670M | $835M |
| Shareholders' equity | $403M | $408M | $435M | $1.24B | $1.32B | $1.39B | $1.28B | $1.38B | $1.35B | $1.37B |
| Retained earnings | $364M | $366M | $405M | $413M | $424M | $516M | $470M | $551M | $634M | $597M |
| Shares (wtd avg diluted) | 13.2M | 13.2M | 13.3M | 15.2M | 17.8M | 17.9M | 17.9M | 17.9M | 17.9M | 17.5M |
Every figure is extracted from QUAKER CHEMICAL CORP’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.